FPCG
TMO icon

Fort Pitt Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Fort Pitt Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$159M Buy
256,315
+3,766
+1% +$2.23M 4.46% 2
2024
Q2 		$140M Buy
252,549
+5,357
+2% +$3.07M 4.24% 3
2024
Q1 		$144M Buy
247,192
+6,758
+3% +$3.79M 4.43% 2
2023
Q4 		$128M Buy
240,434
+59,941
+33% +$29M 4.19% 3
2023
Q3 		$91.4M Buy
180,493
+74,107
+70% +$39.5M 3.43% 6
2023
Q2 		$55.5M Buy
106,386
+3,805
+4% +$2.05M 2.04% 25
2023
Q1 		$59.1M Buy
102,581
+1,458
+1% +$822K 2.28% 18
2022
Q4 		$55.7M Buy
101,123
+2,736
+3% +$1.45M 2.27% 20
2022
Q3 		$49.9M Buy
98,387
+242
+0.2% +$135K 2.29% 21
2022
Q2 		$53.3M Buy
98,145
+3,826
+4% +$2.11M 2.32% 20
2022
Q1 		$55.7M Buy
94,319
+15,290
+19% +$8.78M 2.08% 21
2021
Q4 		$52.7M Buy
79,029
+4,525
+6% +$2.83M 1.91% 23
2021
Q3 		$42.6M Buy
74,504
+27,340
+58% +$15M 1.77% 27
2021
Q2 		$23.8M Buy
47,164
+5,618
+14% +$2.65M 0.97% 39
2021
Q1 		$19M Buy
41,546
+6,777
+19% +$3.23M 0.85% 43
2020
Q4 		$16.2M Buy
34,769
+2,233
+7% +$1.05M 0.78% 41
2020
Q3 		$14.4M Buy
32,536
+1,323
+4% +$547K 0.8% 39
2020
Q2 		$11.3M Buy
31,213
+911
+3% +$305K 0.67% 43
2020
Q1 		$8.59M Buy
30,302
+17,423
+135% +$5.49M 0.59% 46
2019
Q4 		$4.08M Sell
12,879
-149
-1% -$45.2K 0.23% 62
2019
Q3 		$3.79M Buy
+13,028
New +$3.73M 0.23% 63

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fort Pitt Capital Group's TMO Position: Q3 2024 in Review

Fort Pitt Capital Group increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q3 2024, buying an estimated $2.23M and bringing the position to 256,315 shares worth $159M. The position accounts for 4.46% of the portfolio, ranked #2.

Fort Pitt Capital Group first reported a position in TMO in Q3 2019 and has held it in 21 quarters since. 2,574 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Fort Pitt Capital Group held 256,315 shares of Thermo Fisher Scientific worth $159M as of Q3 2024.
  • Fort Pitt Capital Group bought 3,766 Thermo Fisher Scientific shares in Q3 2024, an estimated $2.23M.
  • Thermo Fisher Scientific made up 4.46% of Fort Pitt Capital Group's portfolio in Q3 2024, its #2 holding.
  • Fort Pitt Capital Group first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 21 quarters since.
  • 2,574 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Fort Pitt Capital Group's 13F filing for Q3 2024, filed 29 Oct 2024.